Clinical Trial

AI-based Progression and Medication Response Prediction Study in Parkinson's Disease

Study acronym: AI-PMP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The study aims to provide initial PoC validation data of two AI models to predict disease progression and treatment side effects in PD patients using as input patients' demographic, clinical and genetic information, as well as digital biomarker measurements in daily living collected via a smartwatch and a mobile application.
Trial Details
NCT Number NCT07189468
Lead Sponsor University Hospital, Toulouse
Collaborators: Aristotle Univ. of Thessaloniki (Greece)
Conditions PARKINSON DISEASE (Disorder)
Enrollment 100 participants
Start Date 2025-10-06
Primary Completion 2027-04-01 (estimated)
Study Completion 2027-04-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-24